Sort
30,917 grants matching “tumor microenvironment”
Quantitative control of CAR T cells via image-guided delivery and monitoring
$638,831Daniel J. Powell · University Of Pennsylvania · R01 · FY2021 · EB
The tumor ecosystem in cancer progression and immunotherapeutic response
$638,655Alexander Y. Rudensky · Sloan-Kettering Inst Can Research · U54 · FY2020 · CA
Nano immunoconjugates to treat primary and metastatic HER2 positive breast cancer
$638,279Julia Y Ljubimova · Cedars-Sinai Medical Center · R01 · FY2019 · CA
Epigenomic Reprogramming in Patient Derived Models of Colorectal Cancer
$638,270Xiling Shen · Duke University · U01 · FY2018 · CA
Engineered Vaccines for Neoantigen Targeted Cancer Immunotherapy
$638,247John Tanner Wilson · Vanderbilt University · R01 · FY2022 · CA
Project 2: : Systematic discovery of cell-extrinsic mechanisms of cancer drug resistance
$638,188Alex K Shalek · Massachusetts Institute Of Technology · U54 · FY2018 · CA
Non-canonical Wnt-Receptor Signaling and Targeted Therapies
$638,151Thomas J. Kipps · University Of California, San Diego · R01 · FY2021 · CA
Mesothelin-targeted immunotoxins in Pancreatic Cancer
$638,124Christine Alewine · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Modulating the localization and persistence of microbial neoantigen vaccine vectors to enhance therapeutic efficacy
$638,120Nicholas Arpaia · Columbia University Health Sciences · R01 · FY2025 · CA
(PQ5) Mitochondrial Heterogeneity in Melanoma Tumor and Immune Responses
$638,007Gerald S Shadel · Salk Institute For Biological Studies · R01 · FY2022 · CA
The Impact of Tissue Sialylation on Macrophage Polarization and Function
$637,990Brian A Cobb · Case Western Reserve University · R01 · FY2021 · AI
The Impact of Tissue Sialylation on Macrophage Polarization and Function
$637,990Brian A Cobb · Case Western Reserve University · R01 · FY2023 · AI
The Impact of Tissue Sialylation on Macrophage Polarization and Function
$637,990Brian A Cobb · Case Western Reserve University · R01 · FY2022 · AI
Identifying lethal prostate cancer at diagnosis with advanced proteoglycomic, radiomic, and genomic approaches
$637,936Joseph Edward Ippolito · Washington University · R01 · FY2023 · CA
Nano immunoconjugates to treat primary and metastatic HER2 positive breast cancer
$637,908Julia Y Ljubimova · Cedars-Sinai Medical Center · R01 · FY2020 · CA
Targeting Neoantigens in Triple Negative Breast Cancer
$637,864William E Gillanders · Washington University · R01 · FY2021 · CA
Targeting Neoantigens in Triple Negative Breast Cancer
$637,836William E Gillanders · Washington University · R01 · FY2020 · CA
Treating Tumoral Hypoxia via Ultrasound-Guided Oxygen Release for Improving Radiation Therapy
$637,817Paul A Dayton · Univ Of North Carolina Chapel Hill · R01 · FY2020 · CA
Dissecting the Kaposi Sarcoma Tumor Microenvironment at the Single Cell Level
$637,815Warren Phipps · Fred Hutchinson Cancer Center · R01 · FY2021 · CA
Multiscale Modeling of Bone Environment Responses to Metastatic Prostate Cancer
$637,735David Basanta Gutierrez · H. Lee Moffitt Cancer Ctr & Res Inst · U01 · FY2020 · CA
Dynamic Imaging of EMT in the Breast Cancer Microenvironment
$637,623Christopher H Contag · Stanford University · R01 · FY2015 · CA
Reprogramming of mature smooth muscle cells to vascular progenitor cells
$637,559Mary Cm Weiser-Evans · University Of Colorado Denver · R01 · FY2020 · HL
Reprogramming of mature smooth muscle cells to vascular progenitor cells
$637,559Mary Cm Weiser-Evans · University Of Colorado Denver · R01 · FY2021 · HL
Reprogramming of mature smooth muscle cells to vascular progenitor cells
$637,559Mary Cm Weiser-Evans · University Of Colorado Denver · R01 · FY2022 · HL
Viral oncoprotein targeted immune therapy for Merkel cell carcinoma
$637,515Paul Nghiem · University Of Washington · R01 · FY2016 · CA